Log In
Print
BCIQ
Print
Print this Print this
 

Dengue fever vaccine

  Manage Alerts
Collapse Summary General Information
Company Themis Bioscience GmbH
DescriptionVaccine developed using Thermaxyn technology that uses a single measles virus vector expressing the EDIII sequences of all 4 strains of dengue virus
Molecular Target
Mechanism of ActionVaccine
Latest Stage of DevelopmentPreclinical
IndicationDengue fever
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today